Yeole B B, Sunny L
Bombay Cancer Registry, Indian Cancer Society, Mumbai, India.
Indian J Cancer. 2001 Jun-Dec;38(2-4):126-32.
Survival from cancer reflects the aggressiveness of the disease, the effectiveness of treatment and host factors such as age. Population based survival reflects the effectiveness of the overall cancer control strategy in the region. Here we report the survival experience of 740 prostate cancer patients registered by the Mumbai (Bombay) Cancer Registry during 1987-1991. There have been very few reports on survival from cancer in India, mainly because of poor patient follow up and inadequate system of registration of death. This has been largely overcome in this study by means of matching with death certificate of Municipal Corporation, telephone and postal enquiries and active follow up through visits of homes of patients. Scrutiny of medical record was also carried out whenever it was possible. Thus information on survival status as on January 1, 1997 was available for 602 patients (82%). The observed survival was 35.1% and the corresponding relative survival was 41.6%. The clinical extent of disease, treatment given and age of the patient were independent predictors of survival. The observed survival was 49.2% for localised disease, 23.5% for direct extention and regional node involvement and 12.7% for distant metastatis patients.
癌症患者的生存率反映了疾病的侵袭性、治疗效果以及诸如年龄等宿主因素。基于人群的生存率反映了该地区总体癌症控制策略的有效性。在此,我们报告了孟买癌症登记处1987年至1991年期间登记的740例前列腺癌患者的生存情况。关于印度癌症患者生存率的报告极少,主要原因是患者随访不佳以及死亡登记系统不完善。在本研究中,通过与市政公司的死亡证明进行匹配、电话和邮政查询以及通过家访进行积极随访,这一问题在很大程度上得到了克服。只要有可能,还会对病历进行审查。因此,截至1997年1月1日,有602例患者(82%)的生存状况信息可供使用。观察到的生存率为35.1%,相应的相对生存率为41.6%。疾病的临床范围、所接受的治疗以及患者年龄是生存的独立预测因素。局限性疾病患者的观察到的生存率为49.2%,直接扩展和区域淋巴结受累患者为23.5%,远处转移患者为12.7%。